Source: International Congress 2015 – PG16 Sleep and disordered breathing



Rating:

Share or cite this content

Citations should be made in the following way:
Juan Fernando Masa Jiménez (Cáceres, Spain). Type III devices – scoring strategies in limited systems. International Congress 2015 – PG16 Sleep and disordered breathing

Member's Comments

No comment yet.

Related content which might interest you: What type of clinical evidence is needed to assess medical devices? Source: Eur Respir Rev 2016; 25: 259-265 Year: 2016 Exacerbation utilities and durations by type: estimates from Phase III benralizumab studies Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 New treatment concepts in stage IV NSCLC: personalized multidisciplinary approaches Source: Virtual Congress 2021 – Hot topics in thoracic oncology Year: 2021 Multicenter study on the variability of the sleep stage scoring algorithm ARTISANA compared to human experts – Part II: validation phase Source: Eur Respir J 2005; 26: Suppl. 49, 114s Year: 2005 Device type and real-world effectiveness of combination therapy Source: Annual Congress 2010 - Pharmacological treatment in primary care Year: 2010 Multicenter study on the variability of a novel sleep stage scoring algorithm compared to human experts – part I: learning phase Source: Eur Respir J 2004; 24: Suppl. 48, 117s Year: 2004 Assessment of respiratory muscle strength with two different methods in individuals with Mucopolysacchariosis type VI: a pilot study Source: International Congress 2017 – Latest insights into pulmonary rehabilitation in COPD Year: 2017 Prospective evaluation of asthma control using three different classification systems Source: Annual Congress 2011 - Clinical parameters in airway diseases Year: 2011 Therapeutic options for operated adenocarcinoma patients in stages I or II Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012 Developing a new ultrasonic method to assess diaphragm movement and comparing the accuracy with existing methods. Source: International Congress 2017 – Respiratory muscles: evaluation and pathophysiology Year: 2017 Chronious: A new wearable monitoring system for COPD patients Source: Annual Congress 2011 - Update on monitoring airway diseases Year: 2011 New clinical research strategies in thoracic oncology: clinical trial design, adaptive, basket and umbrella trials, new end-points and new evaluations of response Source: Eur Respir Rev 2014; 23: 367-378 Year: 2014 Staging techniques needed for implementing the new staging recommendations  Source: International Congress 2016 – PG7 New guidelines for the classification and staging of lung cancer Year: 2016 Are mobile device applications effective at supporting COPD self-management compared to usual care? Source: International Congress 2019 – M-health/e-health II Year: 2019 Why are so many treatments effective experimentally? A systems biology approach Source: Annual Congress 2012 - Acute lung injury: challenging old paradigms Year: 2012 Workshop 1: Lung Clearance Index – demonstration of devices utilised by the core facility; best practices and different approaches to communication with pharmaceutical companies Source: International Congress 2016 – PD5 Establishing core facilities for measuring clinical trial outcomes  Year: 2016 Wearable technologies in respiratory functional assessment Source: ERS webinar 2021: Wearable technologies in respiratory functional assessment Year: 2021